Properties
What is it?
Composition: Active substance: Pimecrolimus; 1g cream contains 10mg pimecrolimus; Excipients: Sodium hydroxide, anhydrous citric acid, benzyl alcohol, sodium cetostearyl sulfate, mono and diglycerides, cetyl alcohol, stearyl alcohol, propylene glycol, oleyl alcohol, medium-chain triglycerides, purified water. Indications: Treatment of mild to moderate atopic dermatitis in patients aged 2 years and older, when treatment with topical corticosteroids is undesirable or not feasible. This may be: in case of intolerance to topical corticosteroids; in case of insufficient efficacy of topical corticosteroids; when it is necessary to use on the face and neck, where prolonged intermittent use of corticosteroids may be undesirable. Contraindications. Hypersensitivity to pimecrolimus, other macrolactams, or other components of the preparation. Method of administration and dosage: The duration of treatment is determined by the doctor based on the stage and severity of the disease. Elidel can be used for short-term treatment of signs and symptoms of atopic eczema and periodically for long-term prevention of disease exacerbations. Treatment should be initiated at the first signs and symptoms of atopic dermatitis. Elidel should only be applied to areas affected by atopic dermatitis. Elidel is used for the shortest possible duration during exacerbations of the disease. The patient or their caregiver should discontinue the use of Elidel when symptoms disappear. Treatment should be intermittent, short-term, and not prolonged. Elidel should be applied thinly to affected areas twice daily. Studies have shown that periodic use of Elidel for up to 12 months is acceptable. If no improvement is observed within 6 months, or if the condition worsens, the use of Elidel should be discontinued. Use during pregnancy and lactation: Elidel should not be used during pregnancy. Elidel should be prescribed with caution during lactation. A breastfeeding mother may use Elidel, but not on the breast area, to prevent accidental ingestion of the preparation by the newborn's mouth. Children: The use of Elidel is not recommended in children under 2 years of age. In children (2-11 years) and adolescents (12-17 years), the dosage and method of administration do not differ from the recommendations for adult patients. Storage conditions: Store in a place inaccessible to children, at a temperature not exceeding 25C, do not freeze. Shelf life: 2 years. After opening the tube, the preparation should be used within 12 months. Do not use after the expiry date. Dispensing category: Pharmaceutical product group III, over-the-counter.